Issue 5, 2020

Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot

Abstract

The modification of poly(2-hydroxypropyl methacrylate) with a single fucose group per polymer chain enabled macromolecular self-assembly, and the formation of thermoresponsive nanoparticles. In addition, poly(2-hydroxypropyl methacrylate)200 formed a self-healing material that may act as an injectable vehicle and depot for poly(2-hydroxypropyl methacrylate) nanoparticle delivery and localisation at a particular site. In combination, the injectable depot permits the controlled release of doxorubicin from the fucose presenting nanoparticles that it contains following injection. Such thermoresponsive materials are highly promising candidates for the treatment of diseases that may be remedied by exploiting targeted fucose-cell binding, such as pancreatic cancer.

Graphical abstract: Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot

Supplementary files

Article information

Article type
Paper
Submitted
05 May 2020
Accepted
10 Jul 2020
First published
14 Jul 2020
This article is Open Access
Creative Commons BY license

Mater. Adv., 2020,1, 1293-1300

Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot

H. Yu, J. V. Rowley, D. C. Green and P. D. Thornton, Mater. Adv., 2020, 1, 1293 DOI: 10.1039/D0MA00280A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements